Clinical Trial Update: Liraglutide for HIV-associated Neurocognitive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial of liraglutide for HIV-associated neurocognitive disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Metabolic Syndrome
• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Temple University | Conditions: HIV Infection, Diabetes Mellitus Type 2 | Phase 4 | Status: TERMINATED